About Kent & Canterbury Hospital; Clinical Haematology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Kent & Canterbury Hospital; Clinical Haematology
During the past decade, Kent & Canterbury Hospital; Clinical Haematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kent & Canterbury Hospital; Clinical Haematology"
#1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Kent & Canterbury Hospital; Clinical Haematology
According to Clinical.Site data, the most researched conditions in "Kent & Canterbury Hospital; Clinical Haematology" are
"Non-Hodgkin's Lymphoma" (2 trials). Many other conditions were trialed in "Kent & Canterbury Hospital; Clinical Haematology" in a lesser frequency.
Clinical Trials Intervention Types at Kent & Canterbury Hospital; Clinical Haematology
Most popular intervention types in "Kent & Canterbury Hospital; Clinical Haematology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (2 trials), "Bendamustine" (1 trials), "Chemotherapy (Induction Period)" (1 trials), "Cyclophosphamide" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kent & Canterbury Hospital; Clinical Haematology
The vast majority of trials in "Kent & Canterbury Hospital; Clinical Haematology" are
2 trials for "All" genders.
Clinical Trials Status at Kent & Canterbury Hospital; Clinical Haematology
Currently, there are NaN active trials in "Kent & Canterbury Hospital; Clinical Haematology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kent & Canterbury Hospital; Clinical Haematology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kent & Canterbury Hospital; Clinical Haematology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".